Lactulose Fresenius (Lactulose, Liquid)

Lactulose is a synthetic sugar that reaches the colon unchanged, where bacterial enzymes break it down into short‑chain fatty acids. This creates an osmotic gradient that draws water into the bowel, softening stool, and the acidic environment converts ammonia to ammonium, reducing its systemic absorption.

The dose of Lactulose Fresenius is individualized by the prescribing clinician. The prescriber determines the appropriate volume based on the patient’s condition, response, and tolerance, and may adjust it to achieve the desired stool frequency or ammonia reduction.

Safety data for Lactulose Fresenius in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the healthcare professional.

To order Lactulose Fresenius, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose and other osmotic agents such as polyethylene glycol both increase colonic water content. Lactulose additionally acidifies the lumen, which helps trap ammonia, making it the preferred choice for hepatic encephalopathy, whereas polyethylene glycol is often used solely for constipation without the ammonia‑lowering effect.

Lactulose Fresenius should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Lactulose Fresenius is an oral liquid taken by mouth. The prescribed volume is measured with a calibrated device such as a dosing cup or syringe, and can be mixed with a small amount of water or juice if needed for palatability.

The most serious risks include severe dehydration and electrolyte disturbances, particularly hypokalemia, which can occur if the dose is too high or fluid intake is insufficient. Monitoring of fluid balance and electrolytes is essential in at‑risk patients.

Lactulose Fresenius is contraindicated in patients with known or suspected intestinal obstruction, perforation, or severe inflammatory bowel disease. Individuals with a hypersensitivity to lactulose or any component of the formulation should also avoid its use.